It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cell adhesion mediated by selectins (expressed by activated endothelium, activated platelets, and leukocytes) binding to their resepective selectin ligands (expressed by cancer cells) may be involved in metastasis. Therefore, methods of characterizing selectin ligands expressed on human tissue may serve as valuable assays. Presented herein is an innovative method for detecting functional selectin ligands expressed on human tissue that uses a dynamic approach, which allows for control over the force applied to the bonds between the probe and target molecules. This new method of tissue interrogation, known as dynamic biochemical tissue analysis (DBTA), involves the perfusion of molecular probe-coated microspheres over tissues. DBTA using selectin-coated probes is able to detect functional selectin ligands expressed on tissue from multiple cancer types at both primary and metastatic sites.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Russ College of Engineering and Technology, Biomedical Engineering Program, Athens, USA; Russ College of Engineering and Technology, Department of Chemical and Biomolecular Engineering, Athens, USA
2 Russ College of Engineering and Technology, Biomedical Engineering Program, Athens, USA; Heritage College of Osteopathic Medicine, Department of Biomedical Sciences, Athens, USA
3 University of Texas-Medical Branch, Department of Otolaryngology, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964)
4 Russ College of Engineering and Technology, Biomedical Engineering Program, Athens, USA (GRID:grid.176731.5); Russ College of Engineering and Technology, Department of Chemical and Biomolecular Engineering, Athens, USA (GRID:grid.176731.5)
5 Russ College of Engineering and Technology, Biomedical Engineering Program, Athens, USA (GRID:grid.176731.5); Russ College of Engineering and Technology, Department of Chemical and Biomolecular Engineering, Athens, USA (GRID:grid.176731.5); Ohio University, Edison Biotechnology Institute, Athens, USA (GRID:grid.20627.31) (ISNI:0000 0001 0668 7841)